Research Article
A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma
Table 3
Correlation between included genes (signature) and clinical parameters.
| | Id | Age | Gender | Grade | Stage | T | M | N |
| | ETF1 | 0.191 (0.849) | 0.209 (0.834) | −1.899 (0.059) | −1.797 (0.075) | −1.298 (0.197) | 0.547 (0.636) | −1.291 (0.285) | | GSR | 0.782 (0.436) | −1.263 (0.208) | −2.216 (0.028) | −1.886 (0.062) | −2.008 (0.047) | 2.607 (0.093) | 2.35 (0.049) | | SKAP2 | −0.721 (0.473) | 1.488 (0.139) | 1.274 (0.204) | −2.457 (0.016) | −2.009 (0.047) | 1.576 (0.241) | −0.815 (0.474) | | HSPD1 | 0.988 (0.325) | −0.442 (0.659) | −2.609 (0.010) | −1.418 (0.158) | −1.17 (0.244) | 3.016 (0.067) | −1.426 (0.244) | | CACYBP | 2.79 (0.006) | −0.636 (0.526) | −2.635 (0.009) | −1.547 (0.125) | −1.71 (0.090) | 0.38 (0.738) | −0.015 (0.989) | | PNP | 1.614 (0.109) | 1.766 (0.080) | −1.139 (0.256) | −2.781 (0.006) | −2.819 (0.006) | 1.759 (0.202) | −0.813 (0.475) | | Risk score | 0.94 (0.054) | −0.45 (0.654) | −2.687 (0.008) | −2.603 (0.010) | −2.428 (0.017) | 4.473 (0.009) | −1.171 (0.317) |
|
|
The results in table represent correlation coefficient and value; the bold represents significantly different values. |
